ES2109239T3 - 5-(1-aminociclohexil)-2(1h)-piridinona y compuestos relacionados. - Google Patents

5-(1-aminociclohexil)-2(1h)-piridinona y compuestos relacionados.

Info

Publication number
ES2109239T3
ES2109239T3 ES90912876T ES90912876T ES2109239T3 ES 2109239 T3 ES2109239 T3 ES 2109239T3 ES 90912876 T ES90912876 T ES 90912876T ES 90912876 T ES90912876 T ES 90912876T ES 2109239 T3 ES2109239 T3 ES 2109239T3
Authority
ES
Spain
Prior art keywords
sub
hydrogen
rent
aryl
piridinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90912876T
Other languages
English (en)
Inventor
Richard Charles Effland
David Marc Fink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ES2109239T3 publication Critical patent/ES2109239T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE DESCRIBEN LOS COMPUESTOS QUE TIENEN LA FORMULA (I), DONDE N ES 1, 2 O 3; R SUB 1 ES HIDROGENO, FORMILO, ALQUILCARBONILO INFERIOR, ALQUILCARBONILO INFERIOR DE ARILO, ALQUILO INFERIOR, ALQUILO INFERIOR DE ARILO, (A) O (B), R SUB 5 Y R SUB 6 SON INDEPENDIENTEMENTE ALQUILO INFERIOR O ALTERNATIVAMENTE EL GRUPO (C) QUE TOMADO COMO UN TODO ES (D), (E), (F) O (G); R SUB 2 ES HIDROGENO, ALQUILO INFERIOR, ALQUENILO INFERIOR, ALQUILO INFERIOR DE ARILO, -CH SUB 2C (EQUIVALE) CH, (H), (I), (J), R SUB 7 Y R SUB 8 SON INDEPENDIENTEMENTE ALQUILO INFERIOR O ALTERNATIVAMENTE EL GRUPO (K) QUE TOMANDO COMO UN TODO ES (L), (M) O (N); R SUB 3 ES HIDROGENO O ALQUILO INFERIOR; Y R SUB 4 ES HIDROGENO O ALQUILO INFERIOR; CUYOS COMPUESTOS SON UTILES COMO AGENTES ANALGESICOS Y TAMBIEN PARA EL TRATAMIENTO DE VARIAS DISFUNCIONES DE LA MEMORIA.
ES90912876T 1989-08-16 1990-08-16 5-(1-aminociclohexil)-2(1h)-piridinona y compuestos relacionados. Expired - Lifetime ES2109239T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/394,448 US4978663A (en) 1989-08-16 1989-08-16 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility

Publications (1)

Publication Number Publication Date
ES2109239T3 true ES2109239T3 (es) 1998-01-16

Family

ID=23558997

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90912876T Expired - Lifetime ES2109239T3 (es) 1989-08-16 1990-08-16 5-(1-aminociclohexil)-2(1h)-piridinona y compuestos relacionados.

Country Status (14)

Country Link
US (1) US4978663A (es)
EP (1) EP0487602B1 (es)
JP (3) JP2557568B2 (es)
KR (1) KR927003532A (es)
AT (1) ATE155458T1 (es)
AU (1) AU652126B2 (es)
CA (2) CA2332188C (es)
DE (1) DE69031075T2 (es)
DK (1) DK0487602T3 (es)
ES (1) ES2109239T3 (es)
FI (1) FI920637A7 (es)
HU (2) HUT67589A (es)
NO (1) NO920600L (es)
WO (1) WO1991002721A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW473479B (en) 1997-12-19 2002-01-21 Takeda Chemical Industries Ltd Phosphonocephem derivatives, their production and use
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
WO2009033703A1 (en) * 2007-09-14 2009-03-19 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
ES2365966T3 (es) 2007-09-14 2011-10-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-disustituidas.
BRPI0816767B8 (pt) 2007-09-14 2021-05-25 Addex Pharmaceuticals Sa composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos
ES2637794T3 (es) * 2007-11-14 2017-10-17 Janssen Pharmaceuticals, Inc. Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体の調節因子としての３−アザビシクロ［３．１．０］ヘキシル誘導体
BRPI0920354A2 (pt) 2008-10-16 2017-06-27 Addex Pharmaceuticals Sa derivados de indol e benzomorfolina como moduladores de receptores de glutamato metabotrópicos
CN102232074B (zh) 2008-11-28 2014-12-03 奥梅-杨森制药有限公司 作为代谢性谷氨酸盐受体调节剂的吲哚和苯并噁嗪衍生物
SG176021A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BRPI1010831A2 (pt) 2009-05-12 2016-04-05 Addex Pharmaceuticals Sa derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
PT2649069E (pt) 2010-11-08 2015-11-20 Janssen Pharmaceuticals Inc Derivados de 1,2,4-triazolo[4,3-a]piridina e sua utilização como moduladores alostéricos positivos de recetores mglur2
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
HUE045610T2 (hu) 2014-01-21 2020-01-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk
PH12021552653A1 (en) 2014-01-21 2023-07-17 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
CN112409267A (zh) * 2019-08-22 2021-02-26 江苏阿尔法药业有限公司 一种索菲布韦中间体的制备方法
CN112409266A (zh) * 2019-08-22 2021-02-26 江苏阿尔法药业有限公司 一种索菲布韦中间体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903224A (en) * 1972-06-20 F. Czaja Robert Process for the production of pyridones
GB851577A (en) * 1958-03-06 1960-10-19 Parke Davis & Co Pyridine compounds and methods for producing the same
US3655897A (en) * 1971-01-25 1972-04-11 Merck & Co Inc Anti-inflammatory agents
JPS61165372A (ja) * 1985-01-17 1986-07-26 Daicel Chem Ind Ltd ５−ハロピリジン−３−カルボキサミド化合物
DE3823991A1 (de) * 1988-07-15 1990-02-15 Basf Ag Heterocyclisch substituierte (alpha)-aryl-acrylsaeureester und fungizide, die diese verbindungen enthalten

Also Published As

Publication number Publication date
CA2063594C (en) 2002-07-16
JPH09100287A (ja) 1997-04-15
EP0487602A1 (en) 1992-06-03
JPH04507421A (ja) 1992-12-24
DE69031075D1 (de) 1997-08-21
AU652126B2 (en) 1994-08-18
JPH09100288A (ja) 1997-04-15
NO920600L (no) 1992-04-14
NO920600D0 (no) 1992-02-14
FI920637A0 (fi) 1992-02-14
CA2063594A1 (en) 1991-02-17
JP2557568B2 (ja) 1996-11-27
AU6284290A (en) 1991-04-03
JP2708737B2 (ja) 1998-02-04
HU9200461D0 (en) 1992-05-28
EP0487602B1 (en) 1997-07-16
DE69031075T2 (de) 1998-02-26
ATE155458T1 (de) 1997-08-15
CA2332188A1 (en) 1991-02-17
WO1991002721A1 (en) 1991-03-07
HUT67589A (en) 1995-04-28
DK0487602T3 (da) 1998-02-09
US4978663A (en) 1990-12-18
EP0487602A4 (en) 1993-03-17
CA2332188C (en) 2007-01-23
KR927003532A (ko) 1992-12-18
JP2708736B2 (ja) 1998-02-04
FI920637A7 (fi) 1992-02-14

Similar Documents

Publication Publication Date Title
ES2109239T3 (es) 5-(1-aminociclohexil)-2(1h)-piridinona y compuestos relacionados.
MX9700249A (es) Compuestos ariltios como agentes antibacteriales yantivirales.
DE3660286D1 (en) Arylcyclobutylalkyl amines and their use as antidepressive medicines
ES2043830T3 (es) Un metodo para preparar un compuesto de bis-(metilenodioxi)bifenilo.
ES510585A0 (es) Procedimiento para preparar n-heterociclilmetilamidas.
ATE108772T1 (de) Monopersulfate von amino-(poly)percarbonsäuren.
ES552702A1 (es) Procedimiento para la preparacion de nuevas (hetero)-aril-propilaminas
ES2064729T3 (es) Complejos de rutenio (iii) como agentes antineoplasticos.
FI834730A0 (fi) 1-karboxialkanoylperhydro-indol-2-karboxylsyror och deras derivat
MX9301045A (es) Procedimiento para preparar antagonistas receptores de fibrinogeno.
KR910009670A (ko) 이미다졸 살균제
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
AR245699A1 (es) Compuestos derivados de n'-alquil-n,n'-diacilhidrazinas insecticidamente activos y composicion que los comprende.
ES8602798A1 (es) Un procedimiento para la preparacion de nuevos analogos de la mitomicina.
KR830004210A (ko) 2-아미노-3-벤조일-페닐아세트아미드 및 환상 동족체
KR880000381A (ko) 치환 3-아미노-2-벤조일시클로헥스-2-에논과 이를 이용한 제초제 조성물 및 식물체 억제방법
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
DK628487D0 (da) Kemiske forbindelser
ES2053802T3 (es) 1,2-benzoisoxazoles y 1,2-benzoisotiazoles.
ES527739A0 (es) Un procedimiento para preparar derivados de pirimidina
ATE241976T1 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind
KR890016001A (ko) 신규의 치환 아릴 또는 헤테로아릴 디온 및 관련 화합물, 그의 합성 및 그의 용도
ATE31059T1 (de) N-(arylpropyl)-azolylharnstoffe und diese enthaltende fungizide.
DE69004596D1 (de) Benzodiazepin-Analoge.
ES2043778T3 (es) Procedimiento para preparar oxiindanos y tetrahidronaftalenos herbicidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 487602

Country of ref document: ES